Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression

Journal of Innate Immunity

Volumn 3, Issue 6, 2011, Pages 631-638

  Takala, Heikki ^a   Kauppila, Joonas H ^a   Soini, Ylermi ^a,b   Selander, Katri S ^a,d   Vuopala, Katri S ^c   Lehenkari, Petri P ^a   Saarnio, Juha ^a   Karttunen, Tuomo J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c University of Oulu   (Finland)

^d University of Alabama at Birmingham   (United States)

Author keywords

Epithelium; Esophagus; Pattern recognition receptors; Squamous cell carcinoma; Squamous cell dysplasia; Toll like receptor 9

Indexed keywords

TOLL LIKE RECEPTOR 9;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; DISTANT METASTASIS; DYSPLASIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL;

CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EPITHELIAL CELLS; ESOPHAGEAL DISEASES; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; TOLL-LIKE RECEPTOR 9; TUMOR MARKERS, BIOLOGICAL;

EID: 80054944453     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000329115     Document Type: Article

References (34)

1. Fukata M, Abreu MT: Pathogen recognition receptors, cancer and inflammation in the gut. Curr Opin Pharmacol 2009;9:680-687.
2. Kawai T, Akira S: TLR signaling. Cell Death Differ 2006;13:816-825.
3. Barton GM, Kagan JC, Medzhitov R: Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006;7:49-56. (Pubitemid 41823868)
4. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745. (Pubitemid 32015992)
5. Marshak-Rothstein A, Rifkin IR: Immunologically active autoantigens: the role of Tolllike receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007;25:419-441. (Pubitemid 46697913)
6. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL: Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005;202:1131-1139. (Pubitemid 41464506)
7. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Su B, Nestle FO, Zal T, Mellman I, Schroder JM, Liu YJ, Gilliet M: Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007;449:564-569. (Pubitemid 47525141)
8. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ, Gilliet M: Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J Exp Med 2005;202:135-143. (Pubitemid 41002916)
9. Chang YJ, Wu MS, Lin JT, Sheu BS, Muta T, Inoue H, Chen CC: Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by helicobacter pylori involves TLR2/TLR9 and C-SRC-dependent nuclear factor-κB activation. Mol Pharmacol 2004;66:1465-1477. (Pubitemid 39564773)
10. Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS: Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 2006;4:437-447. (Pubitemid 44197039)
11. Ilvesaro JM, Merrell MA, Swain TM, Davidson J, Zayzafoon M, Harris KW, Selander KS: Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 2007;67:774-781. (Pubitemid 46709446)
12. Ren T, Xu L, Jiao S, Wang Y, Cai Y, Liang Y, Zhou Y, Zhou H, Wen Z: Tlr9 signaling promotes tumor progression of human lung cancer cell in vivo. Pathol Oncol Res 2009;15:623-630.
13. Ilvesaro JM, Merrell MA, Li L, Wakchoure S, Graves D, Brooks S, Rahko E, Jukkola-Vuorinen A, Vuopala KS, Harris KW, Selander KS: Toll-like receptor 9 mediates CPG oligonucleotide-induced cellular invasion. Mol Cancer Res 2008;6:1534-1543.
14. Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N, Miyaoka Y, Kazumori H, Ishimura N, Amano Y, Kinoshita Y: Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 2004;173:1406-1416. (Pubitemid 38924322)
15. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL: Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001;167:1882-1885. (Pubitemid 32747491)
16. Akhtar M, Watson JL, Nazli A, McKay DM: Bacterial DNA evokes epithelial IL-8 production by a MAPK-dependent, NF-κB-independent pathway. FASEB J 2003;17:1319-1321.
17. Kauppila JH TH, Selander KS, Lehenkari PP, Saarnio J, Karttunen TJ: Increased Toll-like receptor 9 expression indicates adverse prognosis in esophageal adenocarcinoma. Histopathology, in press
18. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM: CPG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-549.
19. Falk GW: Risk factors for esophageal cancer development. Surg Oncol Clin N Am 2009;18:469-485.
20. Toh Y, Oki E, Ohgaki K, Sakamoto Y, Ito S, Egashira A, Saeki H, Kakeji Y, Morita M, Sakaguchi Y, Okamura T, Maehara Y: Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol 2010;15:135-144.
21. Morita E, Narikiyo M, Yokoyama A, Yano A, Kamoi K, Yoshikawa E, Yamaguchi T, Igaki H, Tachimori Y, Kato H, Saito D, Hanada N, Sasaki H: Predominant presence of streptococcus anginosus in the saliva of alcoholics. Oral Microbiol Immunol 2005;20:362-365. (Pubitemid 41564348)
22. Delima SL, McBride RK, Preshaw PM, Heasman PA, Kumar PS: Response of subgingival bacteria to smoking cessation. J Clin Microbiol 2010;48:2344-2349.
23. Jukkola-Vuorinen A, Rahko E, Vuopala KS, Desmond R, Lehenkari PP, Harris KW, Selander KS: Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer. J Innate Immun 2008;1:59-68.
24. Krieg AM: Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene 2008;27:161-167.
25. Chang YJ, Wu MS, Lin JT, Chen CC: Helicobacter pylori -induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through tlr2/tlr9 and promoter regulation. J Immunol 2005;175:8242-8252.
26. Nurmenniemi S, Kuvaja P, Lehtonen S, Tiuraniemi S, Alahuhta I, Mattila RK, Risteli J, Salo T, Selander KS, Nyberg P, Lehenkari P: Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13. Exp Cell Res 2010;316:2676-2682.
27. Lee JW, Choi JJ, Seo ES, Kim MJ, Kim WY, Choi CH, Kim TJ, Kim BG, Song SY, Bae DS: Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog 2007;46:941-947.
28. Miller LS, Sorensen OE, Liu PT, Jalian HR, Eshtiaghpour D, Behmanesh BE, Chung W, Starner TD, Kim J, Sieling PA, Ganz T, Modlin RL: TGF-α regulates TLR expression and function on epidermal keratinocytes. J Immunol 2005;174:6137-6143. (Pubitemid 40663803)
29. Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M: Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with helicobacter pylori. Int J Med Microbiol 2005;295:179-185. (Pubitemid 40776102)
30. Vaisanen MR, Vaisanen T, Jukkola-Vuorinen A, Vuopala KS, Desmond R, Selander KS, Vaarala MH: Expression of Toll-like receptor-9 is increased in poorly differentiated prostate tumors. Prostate 2010;70: 817-824.
31. Chiron D, Pellat-Deceunynck C, Maillasson M, Bataille R, Jego G: Phosphorothioate-modified tlr9 ligands protect cancer cells against trail-induced apoptosis. J Immunol 2009;183:4371-4377.
32. Erridge C, Burdess A, Jackson AJ, Murray C, Riggio M, Lappin D, Milligan S, Spickett CM, Webb DJ: Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma. Eur J Clin Invest 2008;38:713-720.
33. Schneberger D, Caldwell S, Suri SS, Singh B: Expression of Toll-like receptor 9 in horse lungs. Anat Rec (Hoboken) 2009;292:1068-1077.
34. Opitz B, Eitel J, Meixenberger K, Suttorp N: Role of toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections. Thromb Haemost 2009;102:1103-1109.